Why the study?
Does reducing captopril dosage and frequency maintain antihypertensive efficacy in patients with well-controlled hypertension?
Does reducing captopril dosage and frequency maintain antihypertensive efficacy in patients with well-controlled hypertension?
Answers are grounded in this paper and cite their sources.
The daily dosage and frequency of captopril can be successfully reduced while maintaining antihypertensive efficacy in patients previously well-controlled on higher thrice-daily doses.
1 After a period of 7 +/- 1.4 months of good control of hypertension by thrice daily administration of captopril (85 +/- 9 mg three times a day), captopril was given twice daily and the total dose was progressively reduced to sometimes very low levels in 12 patients. Twice daily administration of captopril 85 +/- 9 mg did not modify blood pressure control. 2 During reduction of captopril dosage to a minimum of 36 +/- 4 mg twice a day, the acute effect of the morning dose of captopril (last dose taken at least 12 hours before study) was assessed. Administration of the morning dose induced a decrease in mean arterial pressure from 112 +/- 4 mm Hg (104 +/- 3 mm Hg during administration of 85 +/- 9 mg) three times a day to 106 +/- 4 mm Hg, an increase in plasma renin activity, and a decrease in plasma aldosterone concentration. 3 These acute effects of captopril suggest that blood pressure was well controlled in the presence of a non-blocked circulating angiotensin-converting-enzyme activity, thus raising the possibility of alternate mechanisms by which captopril reduces arterial pressure. 4 The daily dosage of captopril needed to control hypertension may be reassessed after a certain period of good blood pressure control with 50 to 100 mg captopril three times a day.
No takes yet. Share an insight, caveat, or question.
Mimran et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: